微流体装置原型市场－全球产业规模、份额、趋势、机会及预测（按组件、应用、地区和竞争格局划分，2021-2031年）

全球微流体原型市场预计将从 2025 年的 11.2 亿美元成长到 2031 年的 19.1 亿美元，复合年增长率为 9.31%。

该领域涵盖实验室微通道装置的设计、製造和检验的早期阶段，旨在大规模商业化之前操控微小体积的流体。其成长主要受照护现场诊断需求的不断增长以及晶片器官模型在药物研究中日益普及的驱动，这两者都需要对流体结构进行快速迭代测试。这些具体驱动因素使得在研发阶段迫切需要通用型小规模製造方法。

市场扩张的一大障碍是缺乏标准化的互连接口，这使得原型产品与标准实验室设备和流体处理系统的整合变得复杂。儘管面临这项挑战，但产业环境依然稳健。根据SEMI统计，2024年第四季全球积体电路营收年增29%。这一成长反映了半导体製造技术的坚实基础，这些技术正日益为智慧硅基微流体原型产品的生产提供支援。

市场驱动因素

3D列印和微加工技术的进步正在从根本上改变全球微流体原型市场，使得传统微影术技术无法实现的复杂通道几何结构的快速且经济高效地生产成为可能。这些技术进步使研究人员能够频繁地迭代设计，显着缩短创新实验室晶片应用的上市时间，同时支援现代生物鑑定所需的复杂流体动态。国内製造能力的提升也在加速这一趋势。例如，根据WhatTheyThink杂誌2025年9月发表的报导《美国3D医疗列印市场预计将强劲增长》的文章，作为微流体原型製作的关键驱动因素，美国3D医疗列印市场预计到2024年将达到约95.6亿美元。

对製药和生物医学研发投入的增加，虽然只是次要的催化剂，但却是至关重要的，它为设备开发过程中固有的大量试验阶段提供了所需的资金。随着生物製药公司专注于高通量筛检和个人化医疗，用于支援早期检验的一次性实验原型需求激增。这笔资金的涌入主要得益于联邦政府的支持，美国国家标准与技术研究院 (NIST) 于 2025 年 8 月向中小企业津贴，专门用于支持颗粒分离的先进微流体模组。这些投资反映了整个行业的趋势，根据 Xtalks 于 2025 年 1 月发布的「2024 年 30 大新型医疗设备」报告，美国医疗设备监督管理局 (FDA) 在 2024 年核准了21 种新型医疗器械，这表明源自这些原型的商业化设备正在稳步推进监管审24 年批准了21 种新型医疗器械，这表明衍生这些原型的商业化设备正在稳步推进监管审批进程。

市场挑战

缺乏标准化的互连接口是限制全球微流体原型市场扩充性和发展速度的主要结构性障碍。目前，研究人员和製造商各自为政，建构与现有实验室基础设施不相容的客製化流体连接。这导致每次装置改进都需要客製化设计的介面解决方案。这种碎片化增加了开发成本，并延长了关键的「设计-建造-测试」週期。由于缺乏通用标准，无法实现快速检验所需的无缝自动化和可靠的流体处理，因此从成功的实验室规模原型到商业性化产品的过渡常常停滞不前。

这种互通性瓶颈与不断扩大的工业产能形成鲜明对比，而工业产能的扩张正是为了支持这些技术。根据SEMI更新的2024年《MEMS与感测器晶圆厂至2027年报告》，该产业正积极扩展其基础设施，计画在2024年后投产27家高产能晶圆厂和生产线。虽然这项投资显示已做好大规模生产的准备，但原型製作产业却难以有效率地为这条生产线提供产品。高资本投入的製造能力与目前原型製作的非标准化、劳动密集特性之间的差距，造成了一个摩擦点，直接限制了市场成长率。

市场趋势

为了确保原型产品在机械性能上与最终商业产品相似，市场显然正在从聚二甲基硅氧烷 (PDMS) 转向热塑性塑料，例如环烯烃共聚物 (COC) 和聚甲基丙烯酸甲酯 (PMMA)。这种材料转变有助于弥合「实验室到工厂」的差距，使开发人员能够使用与大规模射出成型相容的基板来检验光学性能和耐化学性。根据 2025 年 10 月 SpecialChem 的报导“POLYVANTIS 在 K 2025 上推出用于微流体的PMMA 和 COC 薄膜”，新推出的用于微流体应用的 PLEXIGLAS PMMA 薄膜在 315 nm 波长处的紫外透射率超过 90%，这是一项关键性能指标可实现光学诊断的可实现光学诊断。

此外，原型製作流程越来越多地采用人工智慧演算法来模拟流体动态，并在实际製造之前对通道几何形状进行虚拟最佳化。这种「数位原型製作」趋势使工程师能够准确预测复杂整合系统的热学和流体行为，从而最大限度地减少试验次数。根据微软在2025年9月发布的题为「AI晶片性能日益提升」的公告，其基于人工智慧设计的晶片微流体原型散热性能比传统冷板技术高出三倍，充分展现了生成式设计和模拟所能实现的卓越性能。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球微流体装置原型市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依组件分类（微流体晶片、微流体帮浦、感测器、连接器、配件/耗材、其他）
  • 依应用领域划分（照护现场血液/尿液分析试剂盒、细胞分离、干细胞研究体外平台、药物疗效监测等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美微流体装置原型市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲微流体元件原型市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区微流体元件原型市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲微流体控元件原型市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲微流体装置原型市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球微流体装置原型市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Fluigent
• Micronit
• Bio-Rad
• Agilent
• Thermo Fisher Scientific
• Raindance
• Sener
• Sphere Fluidics
• Elveflow
• Dolomite Microfluidics

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Microfluidics Prototype Market is projected to expand from USD 1.12 Billion in 2025 to USD 1.91 Billion by 2031, registering a CAGR of 9.31%. This sector encompasses the preliminary phases of design, fabrication, and validation for experimental micro-channel devices aimed at manipulating minute fluid volumes prior to mass commercialization. Growth is primarily fueled by the rising demand for point-of-care diagnostics and the increasing adoption of organ-on-chip models in pharmaceutical research, both of which require the rapid and iterative testing of fluidic architectures. These specific drivers create a distinct need for versatile, low-volume fabrication methods during the developmental stage.

A major obstacle hindering market expansion is the absence of standardized interconnection interfaces, which complicates the integration of prototypes with standard laboratory instrumentation and fluid handling systems. Despite this challenge, the industrial environment remains robust; according to SEMI, global integrated circuit sales increased by 29% year-over-year in the fourth quarter of 2024. This growth reflects a strong foundation for the semiconductor-based manufacturing technologies that increasingly support the fabrication of smart, silicon-based microfluidic prototypes.

Market Driver

Advancements in 3D Printing and Microfabrication Technologies are fundamentally transforming the Global Microfluidics Prototype Market by facilitating the rapid and cost-effective production of complex channel geometries that were previously impossible with traditional lithography. This technological progression empowers researchers to iterate designs frequently, significantly shortening the time-to-market for novel lab-on-a-chip applications while supporting the intricate fluid dynamics needed for modern biological assays. Domestic manufacturing capabilities are further accelerating this trend; for example, according to WhatTheyThink, in September 2025, in the 'U.S. 3D Medical Printing Market Poised for Robust Growth' article, the U.S. 3D medical printing market-a key enabler for microfluidic prototyping-was estimated to have reached approximately $9.56 billion in 2024.

Rising investments in pharmaceutical and biomedical R&D serve as a secondary yet critical catalyst, providing the capital necessary for the extensive trial-and-error phases inherent in device development. As biopharmaceutical companies focus on high-throughput screening and personalized medicine, the demand for disposable, experimental prototypes has surged to assist in early-stage validation. This influx of capital is highlighted by federal support; according to the National Institute of Standards and Technology, in August 2025, in the 'NIST Awards Over $1.8 Million to Small Businesses' announcement, funding was allocated specifically for advanced microfluidic modules to support particle separation. Such investments reflect the broader industry trajectory, where, according to Xtalks, in January 2025, in the 'Top 30 New Medical Devices of 2024' report, the FDA approved 21 novel devices in 2024, indicating a steady regulatory path for commercial devices derived from these prototypes.

Market Challenge

The absence of standardized interconnection interfaces acts as a primary structural barrier limiting the scalability and speed of the Global Microfluidics Prototype Market. Currently, researchers and fabricators operate in silos, creating bespoke fluidic connections that are incompatible with broader laboratory infrastructure, which necessitates custom-engineered interfacing solutions for each device iteration. This fragmentation inflates development costs and extends the critical "design-build-test" cycle, frequently stalling the transition from a successful lab-scale prototype to a commercially viable product because the lack of universal standards prevents the seamless automation and reliable fluid handling required for rapid validation.

This interoperability bottleneck contrasts sharply with the expanding industrial capacity intended to support these technologies. According to SEMI, in the "MEMS & Sensors Fab Report to 2027" updated in 2024, the industry is aggressively expanding infrastructure, with 27 volume fabs and manufacturing lines scheduled to commence operations in 2024 and later. While this investment signals readiness for high-volume production, the prototyping sector struggles to feed this pipeline efficiently; the disparity between highly capitalized manufacturing potential and the non-standardized, labor-intensive nature of current prototyping creates a friction point that directly suppresses market growth rates.

Market Trends

The market is distinctly shifting away from Polydimethylsiloxane (PDMS) in favor of thermoplastics such as Cyclic Olefin Copolymer (COC) and Polymethyl Methacrylate (PMMA) to ensure prototypes mechanically resemble final commercial products. This material transition helps bridge the "lab-to-fab" gap, enabling developers to validate optical properties and chemical resistance using substrates compatible with mass-production injection molding. According to SpecialChem, October 2025, in the 'POLYVANTIS presents PMMA and COC films for microfluidics at K 2025' article, newly introduced PLEXIGLAS PMMA films for microfluidic applications achieved a UV transparency of greater than 90% at 315 nm, a critical performance metric for enabling high-precision optical readouts in diagnostic devices.

Furthermore, prototyping workflows are increasingly incorporating Artificial Intelligence algorithms to simulate fluid dynamics and virtually optimize channel geometries prior to physical fabrication. This "digital prototyping" trend minimizes trial-and-error cycles by allowing engineers to predict thermal and fluidic behaviors in complex integrated systems with high accuracy. According to Microsoft, September 2025, in the 'AI chips are getting hotter' announcement, the company's AI-designed in-chip microfluidic prototype successfully removed heat up to three times better than traditional cold plate technologies, underscoring the superior performance achievable through generative design and simulation.

Key Market Players

• Fluigent
• Micronit
• Bio-Rad
• Agilent
• Thermo Fisher Scientific
• Raindance
• Sener
• Sphere Fluidics
• Elveflow
• Dolomite Microfluidics

Report Scope

In this report, the Global Microfluidics Prototype Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidics Prototype Market, By Component

• Microfluidic Chips
• Microfluidic Pumps
• Sensors
• Connectors
• Accessories & Consumables
• Others

Microfluidics Prototype Market, By Application

• Point-of-Care Blood/Urine Analysis Cartridges
• Cell Separation
• In-Vitro Platforms for Stem Cell Research
• Drug Efficacy Monitoring
• Others

Microfluidics Prototype Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microfluidics Prototype Market.

Available Customizations:

Global Microfluidics Prototype Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microfluidics Prototype Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Microfluidic Chips, Microfluidic Pumps, Sensors, Connectors, Accessories & Consumables, Others)
  • 5.2.2. By Application (Point-of-Care Blood/Urine Analysis Cartridges, Cell Separation, In-Vitro Platforms for Stem Cell Research, Drug Efficacy Monitoring, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Microfluidics Prototype Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microfluidics Prototype Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Microfluidics Prototype Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Microfluidics Prototype Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Application

7. Europe Microfluidics Prototype Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microfluidics Prototype Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Application
  • 7.3.2. France Microfluidics Prototype Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Microfluidics Prototype Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Microfluidics Prototype Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Microfluidics Prototype Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Application

8. Asia Pacific Microfluidics Prototype Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microfluidics Prototype Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Application
  • 8.3.2. India Microfluidics Prototype Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Microfluidics Prototype Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Microfluidics Prototype Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Microfluidics Prototype Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Application

9. Middle East & Africa Microfluidics Prototype Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microfluidics Prototype Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Microfluidics Prototype Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Microfluidics Prototype Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Application

10. South America Microfluidics Prototype Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microfluidics Prototype Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Microfluidics Prototype Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Microfluidics Prototype Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microfluidics Prototype Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fluigent
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Micronit
• 15.3. Bio-Rad
• 15.4. Agilent
• 15.5. Thermo Fisher Scientific
• 15.6. Raindance
• 15.7. Sener
• 15.8. Sphere Fluidics
• 15.9. Elveflow
• 15.10. Dolomite Microfluidics

16. Strategic Recommendations

17. About Us & Disclaimer